The diagnostic tools are in place, but the connection between imaging machines and data management systems needs to be tighter if cardiovascular practices are going to keep up with the ever-growing patient volume, experts at Siemens Medical Solutions said from the American Heart Association's (AHA) Scientific Sessions.
CoreValve’s patented ReValving System, consisting of an 18-French delivery catheter, was used to percutaneously implant ...
Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Toshiba America Medical Systems, Inc. held a grand opening Wednesday of the new Toshiba Education Center, a $6 million ...
The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...
New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...
An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...
Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...
A new study published in the Oct. 30 edition of “Circulation” calls the onset of peripheral arterial disease (PAD) among ...